The Prospective Segeberg TAVI Registry
ConditionAortic Valve Stenosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-100
SponsorSegeberger Kliniken GmbH
About this trial
A single center registry including all patients treated with TAVI at the Heart Center, Bad Segeberg, Germany
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients treated with TAVI
Disqualifiers
None
Trial population
All comers patient population treated with TAVI.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Transcatheter Aortic Valve Implantation
DeviceInterventional replacement of the aortic valve
Treatment groups
No treatment groups listed
Trial outcomes
Primary outcomes
1
Mortality
Cardiovascular and not cardiovascular death
Time frame
Up to 10 yearsSecondary outcomes
1
Structural valve deterioration
Transprosthetic mean pressure gradient ≥40 mmHg and/or ≥20 mmHg rise from baseline OR severe intraprosthetic aortic regurgitation
Time frame
Up to 10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov